###begin article-title 0
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UCP2</italic>
Mutations in UCP2 in Congenital Hyperinsulinism Reveal a Role for Regulation of Insulin Secretion
###end article-title 0
###begin p 1
Conceived and designed the experiments: MdMGB FB CBC PdL DR. Performed the experiments: MdMGB IG FB AA CBC LH YdK. Analyzed the data: MdMGB IG FB CBC PdL DR. Wrote the paper: MdMGB PdL DR.
###end p 1
###begin p 2
###xml 245 253 <span type="species:ncbi:9606">patients</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 445 450 <span type="species:ncbi:9606">human</span>
###xml 488 493 <span type="species:ncbi:9606">human</span>
###xml 548 556 <span type="species:ncbi:9606">children</span>
###xml 782 790 <span type="species:ncbi:9606">children</span>
###xml 845 850 <span type="species:ncbi:4932">yeast</span>
###xml 989 994 <span type="species:ncbi:9606">human</span>
###xml 1123 1129 <span type="species:ncbi:9606">humans</span>
###xml 1227 1232 <span type="species:ncbi:9606">human</span>
Although the most common mechanism underlying congenital hyperinsulinism is dysfunction of the pancreatic ATP-sensitive potassium channel, the pathogenesis and genetic origins of this disease remains largely unexplained in more than half of all patients. UCP2 knockout mice exhibit an hyperinsulinemic hypoglycemia, suggesting an involment of UCP2 in insulin secretion. However, a possible pathogenic role for UCP2 protein in the development of human congenital hyperinsulinism or of any human disease has not yet been investigated. We studied ten children exhibiting congenital hyperinsulinism, without detectable mutations in the known congenital hyperinsulinism-causing genes. Parental-inherited heterozygous UCP2 variants encoding amino-acid changes were found in two unrelated children with congenital hyperinsulinism. Functional assays in yeast and in insulin-secreting cells revealed an impaired activity of UCP2 mutants. Therefore, we report the finding of UCP2 coding variants in human congenital hyperinsulinism, which reveals a role for this gene in the regulation of insulin secretion and glucose metabolism in humans. Our results show for the first time a direct association between UCP2 amino acid alteration and human disease and highlight a role for mitochondria in hormone secretion.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 500 505 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 510 516 510 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 583 586 583 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Nestorowicz1">[1]</xref>
###xml 587 590 587 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Nestorowicz2">[3]</xref>
###xml 657 660 657 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Glaser1">[4]</xref>
###xml 661 664 661 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Otonkoski1">[9]</xref>
###xml 889 893 889 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Glaser2">[10]</xref>
###xml 895 899 895 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-DeLeon1">[11]</xref>
Congenital hyperinsulinism (CHI, OMIM 256450) is a rare genetic disorder characterised by hyperinsulinemic hypoglycemia caused by unpredictable excessive insulin secretion. The severity of the disease varies from a mild form to a severe form which may require surgical removal of the pancreas to protect the brain from damage due to recurrent hypoglycemia. Hyperinsulinism may be caused by a range of biochemical disturbances and molecular defects. Most severe CHI are due to mutations in both genes ABCC8 and KCNJ11 encoding ATP-dependent potassium channel subunits SUR1 and Kir6.2 [1]-[3]. Other mutations have also been identified in several other genes [4]-[9]. However, in approximately 40-50% of all CHI cases, no mutation has been found in any of these known genes, suggesting the existence of other disease-associated genes, especially among those sensitive to diazoxide treatment [10], [11].
###end p 4
###begin p 5
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Fleury1">[12]</xref>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Krauss1">[13]</xref>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Affourtit1">[15]</xref>
###xml 778 782 775 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Chan1">[16]</xref>
###xml 784 788 781 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Chan2">[17]</xref>
###xml 801 805 798 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ucp2</italic>
###xml 863 867 860 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Affourtit2">[18]</xref>
###xml 1067 1071 1064 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Patane1">[19]</xref>
###xml 1073 1077 1070 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Brown1">[20]</xref>
###xml 1235 1239 1232 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-DeSouza1">[21]</xref>
###xml 1327 1335 1324 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gardenia</italic>
###xml 1400 1404 1397 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Zhang1">[22]</xref>
###xml 1508 1512 1505 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ucp2</italic>
###xml 1663 1667 1660 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Zhang2">[23]</xref>
###xml 1674 1678 1671 1675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ucp2</italic>
###xml 1711 1716 1708 1713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1794 1798 1791 1795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Zhang2">[23]</xref>
###xml 1884 1888 1881 1885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ucp2</italic>
###xml 2000 2004 1997 2001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Esterbauer1">[24]</xref>
###xml 2005 2009 2002 2006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Sesti1">[26]</xref>
###xml 716 719 <span type="species:ncbi:10116">rat</span>
###xml 1327 1335 <span type="species:ncbi:114476">Gardenia</span>
###xml 1522 1526 <span type="species:ncbi:10090">mice</span>
###xml 1534 1538 <span type="species:ncbi:10090">mice</span>
###xml 1688 1692 <span type="species:ncbi:10090">mice</span>
###xml 1717 1721 <span type="species:ncbi:10090">mice</span>
###xml 1839 1845 <span type="species:ncbi:9606">humans</span>
###xml 2027 2035 <span type="species:ncbi:9606">patients</span>
###xml 2232 2237 <span type="species:ncbi:9606">human</span>
The mitochondrial uncoupling protein 2 (UCP2), a member of the UCP family, is widely expressed in tissues, including pancreatic islets [12]. Due to the high similarity to UCP1, it has been proposed that active UCP2 induces regulated leak of protons across the inner mitochondrial membrane, and as a result, uncoupled mitochondrial oxidative metabolism from ATP synthesis [13]-[15]. Consequently, although it is debated, UCP2 is predicted to reduce the ATP yield from substrate oxidation. Since in pancreatic beta-cells, ATP is a key signal for glucose sensing and insulin secretion, it was predicted that UCP2 could negatively regulate glucose-stimulated insulin secretion (GSIS). Overexpression of UCP2 in isolated rat pancreatic cells decreased ATP content and inhibited GSIS [16], [17]. Similarly, Ucp2 knockdown by RNAi in pancreatic beta cells enhanced GSIS [18]. Data coming from rodents models and animal experiments support the idea that changes in UCP2 expression and/or activity could contribute to beta cell dysfunction and to the pathogenesis of diabetes [19], [20]. Whole-body partial inhibition of UCP2 expression by antisense oligonucleotide treatment reversed hyperglycemia in models of diabetes and insulin resistance [21]. Consistent with this, inhibition of UCP2 activity by genipin, a natural compound from Gardenia, reversed high glucose- and obesity- induced beta cell function [22]. Also supporting a role for UCP2 in the regulation of insulin secretion have been studies performed in Ucp2 knockout mice. These mice have been shown to exhibit hypoglycaemia as a result of increased GSIS associated with higher ATP levels in isolated islets [23]. When Ucp2 knockout mice were crossed with ob/ob mice, the offspring displayed a significant improvement in glucose tolerance [23]. In addition, there is also evidence in humans that a functional polymorphism in the Ucp2 gene promoter correlated with lower insulin secretion and a higher risk for the development of type 2 diabetes [24]-[26]. Given that many patients with CHI do not have mutations in known CHI-associated genes, and given the implicated role of UCP2 in the regulation of insulin secretion we investigated UCP2 as a new candidate gene involved in human hyperinsulinic states.
###end p 5
###begin title 6
Materials and Methods
###end title 6
###begin title 7
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and genotype analyses
###end title 7
###begin p 8
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 267 273 267 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 275 278 275 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUD1</italic>
###xml 825 829 825 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Sempoux1">[27]</xref>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 53 65 <span type="species:ncbi:9606">participants</span>
###xml 190 198 <span type="species:ncbi:9606">children</span>
###xml 333 341 <span type="species:ncbi:9606">children</span>
###xml 915 923 <span type="species:ncbi:9606">patients</span>
###xml 1119 1127 <span type="species:ncbi:9606">patients</span>
Written informed consent was obtained from all human participants before collecting blood for DNA extraction. The study was approved by Necker-Enfants Malades Hospital review board. Ten CHI children with no detectable mutations by DNA direct sequencing in the ABCC8, KCNJ11, GCK or GLUD1 genes were included in this study. These ten children presenting repeated hypoglycemias (ranging from 0.9 to 2.3, reference range >2.7 mmol/l) associated to high insulin levels (ranging from 5.5 to 40 mU/l, reference range <0.4 in hypoglycemia), consistent with the diagnosis of congenital hyperinsulinism. Hypoglycaemia occurred either at birth (5/10 cases) or in infancy (5/10 cases). Those who underwent surgery (4/10) were subsequently classified as either diffuse CHI (n = 1) according to previously described histological criteria [27] or atypical CHI (n = 3), a mosaic of heterogeneous hyperfunctional islets. The other patients (6/10) were treated medically with diazoxide. The medical sensitivity to diazoxide was defined as the complete normalisation of blood glucose (>3 mmol/l), measured before and after each meal, in patients fed normally. After that intravenous glucose and other medications had been stopped for at least five consecutive days. Resistance to medical treatment was defined as two confirmed blood glucose measurements lower than 3 mmol/l in a 24-hours period.
###end p 8
###begin p 9
###xml 57 61 57 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Brunelle1">[28]</xref>
###xml 293 301 <span type="species:ncbi:9606">patients</span>
Transhepatic selective pancreatic venous catheterization [28] was performed to detect diffuse insulin oversecretion in the whole pancreas or to localize the insulin hypersecretion to a discrete part of the pancreas. Diazoxide and all other drugs were stopped 7 days before catheterization. In patients with focal CHI, transhepatic selective pancreatic venous catheterization typically gave rise to localised and markedly elevated insulin and C-peptide levels in the territory of the lesions, with low levels in the remaining pancreas. Diffuse CHI was considered when increased insulin and C-peptide levels were found throughout the whole pancreas.
###end p 9
###begin p 10
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UCP2</italic>
###xml 221 225 221 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UCP2</italic>
###xml 276 283 276 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003850-t001">Table 1</xref>
###xml 758 762 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Benit1">[29]</xref>
###xml 930 937 879 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003850-t001">table 1</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human UCP2 gene was screened by denaturating high performance liquid chromatography (DHPLC). Genomic DNA was purified from peripheral blood leukocytes according to standard procedures. Primers designed for amplifying UCP2 exons and exon-intron boundaries are indicated in Table 1. PCR amplifications consisted of an initial denaturation at 94degreesC for 5 min, followed by 30 cycles at 94degreesC for 30 sec, 65degreesC for 30 sec and 72degreesC for 1 min, and a final extension at 72degreesC for 10 min. The PCR products were denatured at 95degreesC for 5 min and allowed to cool to 25degreesC for the formation of heteroduplexes. DHPLC was carried out using a Transgenomic WAVE DHPLC and DNASep column (Transgenomictrade mark) as previously described [29] . For analysis, a flow rate of 0.9 ml/min was used, with the buffer (0.1 M triethylammonium acetate, 25% acetonitrile) gradient increased for 3.5 min, as indicated in table 1. PCR products displaying abnormal DHPLC patterns were purified and directly sequenced using the PRISMtrade mark Ready Reaction Sequencing Kit (Perkin-Elmer) on an automatic sequencer (ABI 3100). All procedures were approved by the review board of the Necker-Enfants Malades Hospital.
###end p 10
###begin title 11
PCR an DHPLC conditions
###end title 11
###begin title 12
###xml 11 16 <span type="species:ncbi:4932">yeast</span>
Vector for yeast expression and site-directed mutagenesis
###end title 12
###begin p 13
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Archaga1">[30]</xref>
###xml 427 454 427 454 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GAAGGGTTCCGaGatCTCTGGAAAGGG</named-content>
###xml 464 492 464 492 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GAAGGGTTCCGcGaGCgTCTGGAAAGGG</named-content>
###xml 502 533 502 533 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTGCTCGTAATGatATcGTCAACTGTGCTGA</named-content>
###xml 543 575 543 575 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GAAGGAGGGGCCtCGAGgaTTCTACAAAGGGT</named-content>
###xml 22 27 <span type="species:ncbi:9606">human</span>
###xml 69 76 <span type="species:ncbi:9606">patient</span>
###xml 83 90 <span type="species:ncbi:9606">patient</span>
Wild-type and mutated human UCP2 (hUCP2) cDNA sequences (as found in patient 1 and patient 2 ) were introduced into the pYeDP-1/8-10 vector as described previously [30] . Site-directed mutagenesis was performed using the QuickChange Site-Directed Mutagenesis Kit according to the manufacturer's instructions (Stratagene, La Jolla, California, USA). Sequences of the synthetic oligonucleotides used were as follows (5' to 3') : GAAGGGTTCCGaGatCTCTGGAAAGGG(G174D) ; GAAGGGTTCCGcGaGCgTCTGGAAAGGG(L175V) ; TTGCTCGTAATGatATcGTCAACTGTGCTGA(A187D) ; GAAGGAGGGGCCtCGAGgaTTCTACAAAGGGT(A268G). Plasmids were sequenced to confirm the introduction of expected mutations by automatic DNA sequencing.
###end p 13
###begin p 14
###xml 115 139 115 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 338 342 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Pecqueur1">[31]</xref>
###xml 22 27 <span type="species:ncbi:9606">human</span>
###xml 115 139 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 251 256 <span type="species:ncbi:4932">yeast</span>
###xml 327 332 <span type="species:ncbi:9606">human</span>
Wild type and mutated human UCP2 cDNA sequences cloned into the pYeDP-1/8-10 vector were introduced in the diploid Saccharomyces cerevisiae strain W303 by electroporation. Expression levels and mitochondrial targeting were analyzed by western blot of yeast mitochondrial preparations with polyclonal hUCP2 605 antibody against human UCP2 [31].
###end p 14
###begin title 15
###xml 13 18 <span type="species:ncbi:4932">yeast</span>
Isolation of yeast mitochondria and spheroplasts
###end title 15
###begin p 16
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Archaga1">[30]</xref>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Averet1">[32]</xref>
###xml 44 50 <span type="species:ncbi:4932">yeasts</span>
###xml 101 106 <span type="species:ncbi:4932">yeast</span>
###xml 214 219 <span type="species:ncbi:4932">Yeast</span>
Mitochondria were isolated from transformed yeasts grown overnight in SG medium (2% galactose, 0.67% yeast nitrogen base, 0.1% casamino acids, 20 mg/L tryptophan and 40 mg/L adenine) as previously described [30] . Yeast spheroplasts were also prepared from overnight cultures growing in SG medium according to Averet et al. [32] .
###end p 16
###begin title 17
###xml 42 47 <span type="species:ncbi:4932">yeast</span>
Proton leak measurements in permeabilized yeast spheroplasts
###end title 17
###begin p 18
###xml 139 140 133 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 416 417 404 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 472 476 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Locke1">[33]</xref>
Spheroplasts were permeabilized with 0.2 mg/ml nystatin at 30degreesC in respiration medium containing 1 M sorbitol, 0.5 mM EGTA, 2 mM MgSO4, 1.7 mM NaCl, 10 mM potassium phosphate (pH 6.8), 0.1% BSA. Mitochondrial respiration was measured at 20degreesC in the presence of 6 mM NADH with an oxygen electrode. Mitochondrial membrane potential was simultaneously determined with a home-made tetraphenylphosphonium (TPP+) electrode prepared according to published procedures [33] . The amount of spheroplasts used in the experiments was adjusted every day to obtain always the same maximal respiratory rate in the presence of an uncoupler (1 microM FCCP). The initial state 4 of respiration was obtained in the presence of 10 microg/ml oligomycin . Respiratory chain activity was gradually inhibited by the addition of increasing concentrations of potassium cyanide (ranging from 1 to 300 microM).
###end p 18
###begin title 19
Adenovirus generation for expression of UCP2 mutants in insulin-secreting mammalian cells
###end title 19
###begin p 20
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-He1">[34]</xref>
###xml 406 409 406 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP</italic>
###xml 831 834 831 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP</italic>
###xml 203 210 <span type="species:ncbi:9606">patient</span>
###xml 217 224 <span type="species:ncbi:9606">patient</span>
###xml 235 238 <span type="species:ncbi:10116">rat</span>
###xml 294 297 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 587 590 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 869 874 <span type="species:ncbi:9606">human</span>
Recombinant adenoviruses were generated according to the homologous recombination pAdEasy system as described [34] . The full-length hUCP2 cDNA as well as the cDNAs carrying UCP2 mutations equivalent to patient 1 and patient 2 and the rat UCP1 cDNA were cloned into the shuttle vector pAdTrack-CMV. This vector allows the production of green fluorescent protein (GFP)-trackable viruses, as it contains the GFP gene in tandem with the transgene. Expression of both genes is under control of different cytomegalovirus promoters. Homologous recombination between the pAdEasy-1 and pAdTrack-CMV vectors and production of the wild type (AdhUCP2), mutated hUCP2 (AdhU2Patient1 and AdhU2Patient2) and rUCP1 (AdrUCP1) adenoviruses were performed at the Laboratoire de Therapie Genique (INSERM, Nantes-France). An adenovirus containing the GFP gene and the inverted sequence of human UCP2 cDNAwas used as control (Adcontrol).
###end p 20
###begin title 21
Cell culture and adenoviral infection
###end title 21
###begin p 22
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Merglen1">[35]</xref>
###xml 357 358 343 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 461 462 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 590 591 576 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 627 628 613 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 4 7 <span type="species:ncbi:10116">rat</span>
The rat insulinoma cell line INS-1E was provided by Dr. P. Maechler (University of Geneva, Switzerland) [35]. Cells were seeded in 6-well plates and maintained in RPMI 1640 medium containing 10% FCS, 10 mM HEPES, 1 mM sodium pyruvate, 50 microM 2-mercaptoethanol, 4 mM glutamine, 100 IU/ml penicillin and 100 microg/ml streptomycin at 37degreesC under 5% CO2. The cells were infected at near confluence with Adcontrol, AdhUCP2 and AdrUCP1 viral stocks at 5.2x106 plaque-forming units (pfu)/ml. To obtain similar amounts of heterologous protein expressed, the cells were infected with 1.3x106 pfu/ml of AdhUCP2Patient1 or 2.6x106 pfu/ml of AdhUCP2Patient2 viral stocks. The virus was applied to cells for 4 h in the absence of serum. The cells were then washed of virus and supplemented with 10% serum-containing RPMI 1640 for 48 h.
###end p 22
###begin title 23
Mitochondrial isolation from INS-1E cells and western blot analysis
###end title 23
###begin p 24
###xml 82 83 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 334 338 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Pecqueur1">[31]</xref>
###xml 461 464 <span type="species:ncbi:10116">rat</span>
Cells were washed twice with PBS, scraped and collected by centrifugation at 2000 g for 5 min at 4degreesC. Mitochondria were isolated from cells. 10 microg of mitochondrial proteins were resolved by SDS-PAGE and transferred to nitrocellulose membranes before inmunoblotting. UCP2 protein was detected with the anti-hUCP2 (605 batch) [31] or anti-UCP2 (C-20) (Santa Cruz Biotechnology, Inc, Santa Cruz, CA, USA) antibodies. For UCP1 detection a polyclonal anti-rat UCP1 antibody prepared in the laboratory was used. Anti-VDAC/porin antibody (Sigma-Aldrich, St Louis, MO, USA) was used as loading control of equivalent amount of mitochondrial proteins.
###end p 24
###begin title 25
Assay of insulin secretion
###end title 25
###begin p 26
###xml 323 324 323 324 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 336 337 336 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 339 340 339 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 353 354 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 367 368 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 931 933 917 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DC</italic>
###xml 827 830 <span type="species:ncbi:10116">rat</span>
24 h after adenoviral infection, INS-1E cells were cultured overnight in RPMI 1640 medium containing 5 mM glucose and 10% FCS. Cells were washed and preincubated for 1 h in RPMI medium without glucose and 1% FCS. The medium was replaced by 1 ml of Krebs-Ringer bicarbonate buffer (KRBH) (135 mM NaCl, 3.6 mM KCl, 5 mM NaHCO3, 0.5 mM NaH2PO4, 0.5 mM MgCl2, 1.5 mM CaCl2, 10 mM HEPES pH 7.4 and 0.1 % fatty acid-free BSA) with 2.5 mM glucose. When indicated, 32 microM retinoic acid was added to KRBH medium. After 30 min incubation at 37degreesC, the cells were incubated for another 30 min with KRBH containing 15 mM glucose. When indicated, 32 microM retinoic acid was added to KRBH medium. The medium was collected and cleared of non adherent cells. Insulin content in the supernatants was determined by radioimmunoassay for rat insulin (Linco Research, St. Charles, MO). Total cell protein was determined for each well with the DC protein assay (Bio-Rad).
###end p 26
###begin title 27
Statistical Analysis
###end title 27
###begin p 28
###xml 79 80 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 168 169 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Data are presented as means+/-S.E.M. Results were compared by Student's paired t test or one-way ANOVA, where applicable. The level of significance were indicated as * p<0.01 and ** p<0.001.
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
Molecular studies
###end title 30
###begin p 31
###xml 78 99 78 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 269 275 269 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 277 280 277 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 284 289 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUD1</italic>
###xml 501 509 501 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003850-g001">Figure 1</xref>
###xml 973 981 973 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003850-g001">Figure 1</xref>
###xml 1165 1173 1165 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003850-g001">Figure 1</xref>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 192 200 <span type="species:ncbi:9606">children</span>
###xml 455 463 <span type="species:ncbi:9606">patients</span>
###xml 608 616 <span type="species:ncbi:9606">patients</span>
###xml 684 691 <span type="species:ncbi:9606">patient</span>
###xml 1030 1037 <span type="species:ncbi:9606">Patient</span>
Details of hypoglycemias and high insulin levels in CHI patients are given in Materials and Methods section. PCR fragments of UCP2 exons were synthetized from peripheral blood leukocyte of 10 children with no detectable mutations by DNA direct sequencing in the ABCC8, KCNJ11, GCK or GLUD1 genes. Each PCR reaction was subjected to DHPLC analysis and their corresponding elution profiles were analyzed. Abnormal DHPLC pattern was detected for 2 unrelated patients, born to non-consanguineous parents (Figure 1). DNA sequence analysis identified respectively 3 and 1 heterozygous single nucleotide changes in patients 1 and 2, all of them leading to an amino acid change. Mutations of patient 1 consisted of a G to A transition at nt 521 changing a conserved glycine into an aspartic acid (G174D), a C to G transversion at 523 nt changing a conserved leucine into a valine (L175V) and a C to A transition at nt 560 changing a conserved alanine into an aspartic acid (A187D, Figure 1). All mutations were inherited from her father. Patient 2 mutation, inherited from her mother, was a C to G transversion at nt 803 changing a conserved alanine into a glycine (A268G, Figure 1).
###end p 31
###begin title 32
Pedigree of Families 1 and 2 with missense heterozygous sequence variations in the UCP2 gene.
###end title 32
###begin p 33
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UCP2</italic>
###xml 28 35 <span type="species:ncbi:9606">Patient</span>
###xml 211 218 <span type="species:ncbi:9606">Patient</span>
A. Pedigree: Family 1 (F1): Patient 1 had neonatal hypoglycaemia, was sensitive to diazoxide and resolved spontaneously at age 1 year. Her parents did not present clinical signs of hypoglycaemia. Family 2 (F2): Patient 2 developed hypoglycaemia at 8 month of age, sensitive to diazoxide. His mother presented seizures in infancy and occasional hypoglycaemia. Individuals carrying heterozygous UCP2 sequence variations are indicated by partly closed and partly open symbols. B. DHPLC patterns (upper part) and corresponding DNA sequences (lower part) of family 1 and family 2.
###end p 33
###begin p 34
###xml 176 184 176 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003850-g002">Figure 2</xref>
###xml 599 607 591 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003850-g002">Figure 2</xref>
###xml 47 55 <span type="species:ncbi:9606">patients</span>
###xml 229 236 <span type="species:ncbi:9606">patient</span>
###xml 401 408 <span type="species:ncbi:9606">patient</span>
###xml 481 488 <span type="species:ncbi:9606">patient</span>
The amino acid changes identified in these two patients were not found in 100 control subjects. All these residues are highly conserved in UCP2 protein from different species (Figure 2). The amino acids G174 and L175, mutated in patient 1, are localised at the end of the second matrix loop, just before nucleation of the fourth transmembrane alpha-helix. The residue A187, involved also in the first patient, is into the fourth transmembrane alpha-helix. The A268, mutated in the patient 2, is located at the end of the third matrix hydrophilic loop, before the sixth transmembrane domain of UCP2 (Figure 2).
###end p 34
###begin title 35
###xml 30 38 <span type="species:ncbi:9606">patients</span>
Amino acid changes in UCP2 of patients 1 and 2 and conservation among species.
###end title 35
###begin p 36
###xml 72 84 72 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 115 132 115 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rattus norvegicus</italic>
###xml 163 180 163 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Phodopus sungorus</italic>
###xml 210 222 210 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus musculus</italic>
###xml 253 269 253 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Canis familiaris</italic>
###xml 300 310 300 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sus scrofa</italic>
###xml 341 356 341 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyprinus carpio</italic>
###xml 387 398 387 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Danio rerio</italic>
###xml 696 700 692 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-PebayPeyroula1">[51]</xref>
###xml 72 84 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 115 132 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 163 180 <span type="species:ncbi:10044">Phodopus sungorus</span>
###xml 210 222 <span type="species:ncbi:10090">Mus musculus</span>
###xml 253 269 <span type="species:ncbi:9615">Canis familiaris</span>
###xml 300 310 <span type="species:ncbi:9823">Sus scrofa</span>
###xml 341 356 <span type="species:ncbi:7962">Cyprinus carpio</span>
###xml 387 398 <span type="species:ncbi:7955">Danio rerio</span>
###xml 802 810 <span type="species:ncbi:9606">patients</span>
###xml 901 908 <span type="species:ncbi:9606">Patient</span>
###xml 915 922 <span type="species:ncbi:9606">Patient</span>
Comparison of the aminoacid sequences of the second moiety of UCP2 from Homo sapiens (GenBank Accession NP003346), Rattus norvegicus (GenBank Accession NP062227), Phodopus sungorus(GenBank Accession AAG33984), Mus musculus (GenBank Accession NP035801), Canis familiaris (GenBank Accession BAA90457), Sus scrofa (GenBank Accession NP999454), Cyprinus carpio (GenBank Accession CAB46248), Danio rerio (GenBank Accession NP571251). The multiple sequence alignment was carried out with Clustal X (v. 1.8) analysis software. The UCP2 consensus sequence was calculated from the site . The ribbon cartoon symbolizes the predicted alpha-helix domains according to the 3D structure of the ADP/ATP carrier [51]. The putative transmembrane motifs are marked in grey background and the residues mutated in the two patients in dark grey background. Bold letters in the upper line represent the aminoacids found in Patient 1 and Patient 2.
###end p 36
###begin p 37
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 13 17 <span type="species:ncbi:9606">girl</span>
Patient 1, a girl, was born at gestational age of 38 weeks (birth weight 3590 g, length 51.5 cm, head circumference 34 cm) from two unrelated Caucasian parents. She developed neonatal hypoglycaemia and was successfully treated by diazoxide during 1 year (data not shown). After this time, diazoxide was stopped without a recurrence of hypoglycaemia. The parents were healthy.
###end p 37
###begin p 38
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 18 22 <span type="species:ncbi:9606">girl</span>
###xml 499 504 <span type="species:ncbi:9606">child</span>
Patient 2, also a girl, was born at gestational age of 37 weeks (birth weight 2850 g, birth height 48 cm, head circumference 34 cm) from two unrelated Caucasian parents. She presented with seizures at 8 months of age which revealed hypoglycaemia. Clinical and biological investigations confirmed the diagnosis of hyperinsulinism. Pancreatic venous sampling revealed a diffuse insulin secretion suggesting a diffuse form of CHI that was successfully treated by diazoxide for a period of 2 years. The child was not seen in the department after these two years. Her mother was found to be occasionally hypoglycaemic at adult age and has been treated by an antiepileptic drug for seizures during infancy.
###end p 38
###begin title 39
###xml 22 27 <span type="species:ncbi:4932">yeast</span>
Functional studies in yeast
###end title 39
###begin p 40
###xml 331 339 331 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003850-g003">Figure 3</xref>
###xml 377 381 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Fleury1">[12]</xref>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Rial1">[36]</xref>
###xml 96 101 <span type="species:ncbi:4932">yeast</span>
###xml 198 205 <span type="species:ncbi:9606">patient</span>
###xml 212 219 <span type="species:ncbi:9606">patient</span>
###xml 241 246 <span type="species:ncbi:4932">yeast</span>
###xml 425 430 <span type="species:ncbi:4932">yeast</span>
###xml 671 678 <span type="species:ncbi:9606">patient</span>
###xml 684 691 <span type="species:ncbi:9606">patient</span>
###xml 784 790 <span type="species:ncbi:4932">yeasts</span>
###xml 802 809 <span type="species:ncbi:9606">patient</span>
###xml 816 823 <span type="species:ncbi:9606">patient</span>
As a measure of respiratory uncoupling, we assessed the proton conductance of spheroplasts from yeast overexpressing wild type and the mutated UCP2 proteins carrying the amino acid changes found in patient 1 and patient 2. Spheroplasts from yeast transformed with the empty vector were used as control. The results are depicted in Figure 3. As it has been described previously [12], [36], overexpression of wild type UCP2 in yeast mitochondria shifted the curve upward and to the left, which is consistent with an increase of the proton leak and thus uncoupling of mitochondrial respiration, compared to the control spheroplasts. Expression of the mutated forms of UCP2, patient 1 or patient 2, also uncoupled mitochondrial respiration when compared to control spheroplasts. However, yeasts expressing patient 1 and patient 2 UCP2 proteins, showed lower proton permeability compared to the ones expressing wild type UCP2, suggesting that both mutated proteins were less active than wild type UCP2. The same results were obtained with isolated mitochondria (data not shown).
###end p 40
###begin title 41
###xml 42 47 <span type="species:ncbi:4932">yeast</span>
Comparison of the proton leak kinetics of yeast spheroplasts.
###end title 41
###begin p 42
###xml 260 281 260 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 683 704 683 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 734 735 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 861 862 861 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 143 150 <span type="species:ncbi:9606">patient</span>
###xml 236 242 <span type="species:ncbi:4932">yeasts</span>
Spheroplasts were isolated from control (pYeDP plasmid, black circles), wild type UCP2 (pYeDP-hUCP2, black triangles) and mutated (as found in patient 1 and 2) UCP2 (pYeDP-hU2Patient1, open diamonds and pYeDP-hU2Patient2, grey squares) yeasts as described in "Materials and Methods" section. Mitochondrial membrane potential and respiratory rate were simultaneously recorded and varied by titration with potassium cyanide in the presence of NADH. These experiments were performed in the presence of oligomycin using the same amount of respiratory chain for the different types of spheroplasts as determined from the maximal respiratory rate in the presence of FCCP (for details see "Materials and Methods" section). Respiratory rate (y axis) is represented as the percentage from the maximal respiratory rate (Vmax) in the presence of FCCP. Membrane potential (x axis) is represented as the percentage from the highest membrane potential in state 4 of respiration. Results are means+/-S.E.M. of three independent experiments performed at least in duplicate.
###end p 42
###begin title 43
Functional studies in insulin-secreting cells
###end title 43
###begin p 44
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Merglen1">[35]</xref>
###xml 529 537 529 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003850-g004">Figure 4</xref>
###xml 606 613 606 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">methods</xref>
###xml 1082 1090 1082 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003850-g004">Figure 4</xref>
###xml 1249 1257 1249 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003850-g005">Figure 5</xref>
###xml 1898 1906 1894 1902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003850-g005">Figure 5</xref>
###xml 1935 1939 1931 1935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Rial1">[36]</xref>
###xml 64 72 <span type="species:ncbi:9606">patients</span>
###xml 301 304 <span type="species:ncbi:10116">rat</span>
To assess whether the modification of UCP2 activity observed in patients 1 and 2 could affect insulin secretion in beta cells, we subjected an insulin-secreting pancreatic insulinoma cell line (INS-1E) [35] to adenoviral expression of wild type and mutated UCP2 in mitochondria. Adenovirus expressing rat UCP1 was used as control of uncoupling protein. The adenovirus concentration was adjusted for each construct in order to obtain similar amounts of the UCP2 proteins in the INS-1E cell mitochondria (assessed by western blot, Figure 4). At the concentrations employed for each adenoviral construct (see methods section), more than 95% of the cells were infected and expressed GFP, as evidenced by flow cytometry and fluorescence microscopy (data not shown). Infection of INS-1E cells by the recombinant adenoviruses, Ad-hUCP2, Ad-hU2Patient1and Ad-hU2Patient2, enhanced the mitochondrial content of the corresponding proteins around 15 times compared with that of control cells infected with the highest concentration of adenovirus containing the GFP and the inverted UCP2 cDNA (Figure 4). Insulin secretion by INS-1E cells expressing UCP1, wild type and mutant UCP2 proteins was determined in the presence of 15 mM glucose. Results are shown in Figure 5. As expected, adenoviral UCP2 infection significantly reduced insulin release by INS-1E cells (nearly 40% compared to infection with control adenovirus). In contrast, infection of INS-1E cells with AdhU2Patient 1 or AdhU2Patient 2 did not modify the insulin secretion levels from control values. Similar results were obtained with cells overexpressing UCP1. Actually, this was probably due to the high concentration of cytosolic nucleotides that keeps UCP1 activity inhibited since a decrease of near 40% of the insulin release was observed in INS-1E cells overexpressing UCP1, when UCP1 activity was stimulated by 32 microM retinoic acid (Figure 5), a known activator of UCP1 [36].
###end p 44
###begin title 45
Expression levels of wild type, mutated UCP2 and UCP1 in mitochondrial extracts isolated from insulinoma INS-1E cells after adenoviral infection.
###end title 45
###begin p 46
###xml 232 233 228 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 301 302 297 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 346 347 342 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 382 383 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 693 697 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Pecqueur1">[31]</xref>
###xml 1107 1108 1099 1100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 207 212 <span type="species:ncbi:9606">human</span>
###xml 563 569 <span type="species:ncbi:4932">yeasts</span>
###xml 585 590 <span type="species:ncbi:9606">human</span>
###xml 1019 1024 <span type="species:ncbi:9606">human</span>
###xml 1044 1047 <span type="species:ncbi:10116">rat</span>
###xml 1244 1247 <span type="species:ncbi:10116">rat</span>
###xml 1334 1337 <span type="species:ncbi:10116">rat</span>
Gels were loaded with 10 microg of mitochondrial proteins and analyzed by Western blot. A) INS-1E cells were infected with control adenovirus (Adcontrol, containing the GFP gene and the inverted sequence of human UCP2 cDNA at 5.2x106 plaque-forming units (pfu)/ml) or with wild type (AdhUCP2 at 5.2x106 pfu/ml) or mutated (AdhU2Patient1 at 1.3x106 pfu/ml and AdhU2Patient2 at 2.6x106 pfu/ml) UCP2 adenovirus. Mitochondria-rich fraction from not infected INS-1E cells was also used as control of endogenous UCP2 expression. 1 microg of mitochondrial proteins from yeasts overexpressing human UCP2 (pYeDP-hUCP2) were used as positive control. UCP2 protein was revealed using anti-hUCP2 antibody [31] and anti-UCP2 (C-20) (Santa Cruz Biotechnology, Inc, Santa Cruz, CA). As a control of similar amount of proteins loaded, the membrane was reprobed with anti-VDAC/Porin antibody (Sigma-Aldrich, St Louis, MO, USA). B) INS-1E cells were infected with control (Adcontrol, containing the GFP gene and the inverted sequence of human UCP2 cDNA) or with rat UCP1 adenovirus (AdrUCP1) both at a concentration of 5.2x106 pfu/ml. Mitochondria-rich fraction from not infected INS-1E cells was also used as control of endogenous expression. 40 ng of purified rat UCP1 were used as positive control. UCP1 protein was revealed using a polyclonal anti-rat UCP1 antibody prepared in the laboratory. As a control of similar amount of proteins loaded, the membrane was reprobed with anti-VDAC/Porin antibody (Sigma-Aldrich, St Louis, MO, USA).
###end p 46
###begin title 47
Effect of UCP2 mutations on insulin secretion of INS-1E cells in response to glucose.
###end title 47
###begin p 48
###xml 442 463 442 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 572 576 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Rial1">[36]</xref>
###xml 818 819 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 827 828 821 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 125 128 <span type="species:ncbi:10116">rat</span>
###xml 229 234 <span type="species:ncbi:9606">human</span>
Insulin release by INS-1E cells expressing adenoviral wild type (AdhUCP2), mutated (AdhU2Patient1 and AdhU2Patient2) UCP2 or rat UCP1 (AdrUCP1) compared to control (Adcontrol, containing the GFP gene and the inverted sequence of human UCP2 cDNA). Values represent insulin secreted into the medium as percentage from the insulin secreted by cells infected with control adenovirus (Adcontrol) in the presence of 15 mM glucose (for details see "Materials and Methods" section). 32 microM retinoic acid (RA) was added to the cultures of AdUCP1 infected cells to activate UCP1 [36]. Data are means+/-S.E.M. of at least 6 independent experiments performed in duplicate. The level of statistical significance of the differences between cells infected with control adenovirus and with UCP2 or UCP1 adenovirus is indicated: ** p<0.001 (t test).
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 76 79 76 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Nestorowicz1">[1]</xref>
###xml 80 83 80 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Nestorowicz2">[3]</xref>
###xml 152 155 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 157 160 157 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Glaser1">[4]</xref>
###xml 195 198 195 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Stanley1">[5]</xref>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUD1</italic>
###xml 272 275 272 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Clayton1">[6]</xref>
###xml 303 306 303 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Hojlund1">[7]</xref>
###xml 312 317 312 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 372 375 372 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Pearson1">[8]</xref>
###xml 385 392 385 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC16A1</italic>
###xml 498 501 498 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Otonkoski1">[9]</xref>
###xml 756 760 756 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UCP2</italic>
###xml 1019 1023 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Fleury1">[12]</xref>
###xml 889 893 <span type="species:ncbi:10090">mice</span>
###xml 922 927 <span type="species:ncbi:9606">human</span>
###xml 946 951 <span type="species:ncbi:10090">mouse</span>
Although most severe CHI are due to mutations in both genes ABCC8 and KCNJ11[1]-[3], other mutations have also been identified in the glucokinase gene (GCK) [4], the glutamate dehydrogenase gene [5], (GLUD1), the short-chain L-3-hydroxyacyl-CoA dehydrogenase gene (SCHAD) [6], the insulin receptor gene [7], the HNF4A gene in the setting of maturity-onset diabetes (MODY) [8], and the SLC16A1 gene which encodes monocarboxylate transporter 1 (MCT1) in the setting of exercise-induced hypoglycaemia [9]. Nevertheless, a large number of CHI cases remain unexplained. The importance of ATP level or ATP/ADP ratio in the control of insulin secretion indicates that mitochondria and oxidative metabolism may play an important role in this event. Interestingly, UCP2, which encodes a mitochondrial transporter, was initially presented as a gene possibly linked to obesity and hyperinsulinism in mice since it maps to regions of human chromosome 11 and mouse chromosome 7 that have been linked to hyperinsulinemia and obesity [12].
###end p 50
###begin p 51
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-ProduitZengaffinen1">[37]</xref>
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Affourtit1">[15]</xref>
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Affourtit2">[18]</xref>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-DeSouza1">[21]</xref>
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Zhang1">[22]</xref>
###xml 320 324 320 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ucp2</italic>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Zhang2">[23]</xref>
###xml 587 591 587 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Chan3">[38]</xref>
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Sheets1">[39]</xref>
###xml 682 686 682 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Moynihan1">[40]</xref>
###xml 688 692 688 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Bordone1">[41]</xref>
###xml 863 867 863 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Parton1">[42]</xref>
###xml 869 873 869 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Pecqueur2">[43]</xref>
###xml 1049 1053 1049 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Affourtit1">[15]</xref>
###xml 1055 1059 1055 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Arsenijevic1">[44]</xref>
###xml 1061 1065 1061 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Emre1">[45]</xref>
###xml 1110 1112 1110 1112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1120 1124 1120 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Graier1">[46]</xref>
###xml 1246 1250 1246 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Nicholls1">[47]</xref>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
In agreement with an expected role for UCP2 in the regulation of insulin secretion, its ability to inhibit insulin secretion in animals, although it was questionned [37], was largely documented both using experimental modulations of UCP2 level [15]-[18], [21] or activity [22] in insulin-secreting cells and analysis of Ucp2-null mice [23]. In addition, other animal studies suggested that UCP2-mediated control of insulin secretion is a physiologically-relevant mechanism of the metabolic response to fasting since UCP2 has been proposed to keep insulin secretion low during starvation [38], [39], this function being under the control of the transcription co-repressor, surtuin-1 [40], [41]. UCP2 negatively regulates glucose sensing in hypothalamic neurons and participates to metabolic switch from glucose metabolism to fatty acid oxidation during starvation [42], [43]. In addition to a possible role as a regulator of ATP level, it has also been proposed that UCP2 could either act through a modulation of ROS levels by mitochondrial activity [15], [44], [45], or through a regulation of mitochondrial Ca2+ uptake [46]. Undoubtedly, there is still an uncertainty regarding the mechanism explaining the activity of UCP2 and other novel UCPs [47] and in the present study we did not investigate the precise mechanism allowing UCP2 to inhibit insulin secretion. This question will require further studies.
###end p 51
###begin p 52
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UCP2</italic>
###xml 706 710 706 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SUR1</italic>
###xml 710 714 710 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Huopio1">[48]</xref>
###xml 716 720 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Magge1">[49]</xref>
###xml 722 725 722 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 725 728 725 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Glaser1">[4]</xref>
###xml 733 738 733 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUD1</italic>
###xml 738 741 738 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Stanley1">[5]</xref>
###xml 753 757 753 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UCP2</italic>
###xml 908 912 908 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ucp2</italic>
###xml 981 985 981 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Saleh1">[50]</xref>
###xml 1145 1149 1145 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ucp2</italic>
###xml 1164 1168 1164 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Patane1">[19]</xref>
###xml 82 88 <span type="species:ncbi:9606">humans</span>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 172 180 <span type="species:ncbi:9606">patients</span>
###xml 327 335 <span type="species:ncbi:9606">children</span>
###xml 897 901 <span type="species:ncbi:10090">mice</span>
###xml 1016 1023 <span type="species:ncbi:9606">infants</span>
###xml 1238 1246 <span type="species:ncbi:9606">children</span>
Despite many animal studies, no report of a role for UCP2 in insulin secretion in humans was described. The data obtained in mice prompted us to look for UCP2 mutations in patients presenting abnormal insulin secretion. The familial pattern of moderate hyperinsulinism noted in the present study, with more severe phenotype in children than in the carrier parent, suggested an autosomal dominant inheritance with variable expressivity and/or incomplete penetrance. However, it is important to keep in mind that within moderate forms of hyperinsulinism, hypoglycemia can be undiagnosed. Similar intrafamiliar variability was also reported in dominant forms of hyperinsulinism related to other genes such as SUR1[48], [49], GCK[4] and GLUD1[5]. As far as UCP2 is concerned, age-depending genetic and environmental factors may be involved in its regulation. According with this, it has been shown in mice, that Ucp2 expression increased after birth and decreased later on in the life [50]. In addition, as newborns and infants have a higher nutritional intake (in g/kg body weight and day) than adults, and as glucose and fatty acids increased the Ucp2 transcription [19], UCP2 dysfunction may have higher physiopathological implications in children than in adults.
###end p 52
###begin p 53
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UCP2</italic>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Fleury1">[12]</xref>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Chan1">[16]</xref>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Affourtit2">[18]</xref>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003850-Rial1">[36]</xref>
###xml 81 86 <span type="species:ncbi:4932">yeast</span>
###xml 257 265 <span type="species:ncbi:9606">patients</span>
###xml 380 385 <span type="species:ncbi:4932">yeast</span>
###xml 585 593 <span type="species:ncbi:9606">patients</span>
The two procedures used to assay the activity of the UCP2 mutants, expression in yeast or expression in insulinoma cells, were previously used by us and others [12], [16], [18], [36]. Taken together, these data show that the mutations identified from 2 CHI patients are associated with a loss-of-function of the UCP2 protein corresponding to a loss of uncoupling activity seen in yeast. As a result, whereas the wild type UCP2 inhibits insulin secretion by pancreatic beta cells, the mutated UCP2 promote insulin secretion and as such can explain the hyperinsulinism observed in these patients.
###end p 53
###begin p 54
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UCP2</italic>
###xml 92 97 <span type="species:ncbi:9606">human</span>
###xml 279 287 <span type="species:ncbi:9606">patients</span>
###xml 607 613 <span type="species:ncbi:9606">humans</span>
This is the first time that a role for UCP2 in insulin secretion is shown to be relevant in human disease. These novel findings may contribute to define the pathogenesis and genetic origins of congenital hyperinsulinism which remains largely unexplained in more than half of all patients, and could have wider implications for unexplained hypoglycaemia and impaired glucose sensitivity. These data demonstrate that UCP2 should be added to the growing list of genes in which mutations can lead to CHI, and introduce UCP2 as a new player in the control of insulin secretion and glucose sensing by ss-cells in humans. In addition, these results also reinforce the critical role played by mitochondria in the control of insulin secretion.
###end p 54
###begin p 55
The authors are indebted to Dr P.Maechler for the kind gift of Ins-1E cells. The authors wish to thank Dr Eduardo Rial (CIB/CSIC, Madrid, Spain) for his excellent assistance during this work, Dr Mario Garcia Lacoba and Pilar Zaragoza (CIB/CSIC, Madrid, Spain) for their expert technical aid. They also thank Drs Claire Pecqueur and Nathan Hellman for careful reading of the manuscript.
###end p 55
###begin title 56
References
###end title 56
###begin article-title 57
Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews.
###end article-title 57
###begin article-title 58
The molecular basis for familial persistent hyperinsulinemic hypoglycemia of infancy.
###end article-title 58
###begin article-title 59
A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism.
###end article-title 59
###begin article-title 60
Familial hyperinsulinism caused by an activating glucokinase mutation.
###end article-title 60
###begin article-title 61
###xml 38 45 <span type="species:ncbi:9606">infants</span>
Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene.
###end article-title 61
###begin article-title 62
Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion.
###end article-title 62
###begin article-title 63
###xml 97 102 <span type="species:ncbi:9606">human</span>
A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene.
###end article-title 63
###begin article-title 64
###xml 50 58 <span type="species:ncbi:9606">patients</span>
Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene.
###end article-title 64
###begin article-title 65
Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic beta cells.
###end article-title 65
###begin article-title 66
Genetics of neonatal hyperinsulinism.
###end article-title 66
###begin article-title 67
Mechanisms of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates.
###end article-title 67
###begin article-title 68
Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat. Genet.
###end article-title 68
###begin article-title 69
A significant portion of mitochondrial proton leak in intact thymocytes depends on expression of UCP2.
###end article-title 69
###begin article-title 70
The mitochondrial uncoupling-protein homologues.
###end article-title 70
###begin article-title 71
Novel uncoupling proteins.
###end article-title 71
###begin article-title 72
Increased uncoupling protein-2 levels in ss-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action.
###end article-title 72
###begin article-title 73
Uncoupling proteins: role in insulin resistance and insulin insufficiency.
###end article-title 73
###begin article-title 74
Uncoupling protein-2 contributes significantly to high mitochondrial proton leak in INS-1E insulinoma cells and attenuates glucose-stimulated insulin secretion.
###end article-title 74
###begin article-title 75
Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition.
###end article-title 75
###begin article-title 76
###xml 80 85 <span type="species:ncbi:9606">human</span>
Glucose induces and leptin decreases expression of uncoupling protein-2 mRNA in human islets.
###end article-title 76
###begin article-title 77
Inhibition of UCP2 expression reverses diet-induced diabetes mellitus by effects on both insulin secretion and action.
###end article-title 77
###begin article-title 78
Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced beta cell dysfunction in isolated pancreatic islets.
###end article-title 78
###begin article-title 79
Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, ss cell dysfunction, and type 2 diabetes.
###end article-title 79
###begin article-title 80
###xml 106 112 <span type="species:ncbi:9606">humans</span>
A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans.
###end article-title 80
###begin article-title 81
###xml 126 132 <span type="species:ncbi:9606">humans</span>
A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans.
###end article-title 81
###begin article-title 82
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects.
###end article-title 82
###begin article-title 83
Neonatal hyperinsulinemic hypoglycemia: heterogeneity of the syndrome and keys for differential diagnosis.
###end article-title 83
###begin article-title 84
###xml 31 38 <span type="species:ncbi:9606">infants</span>
###xml 43 51 <span type="species:ncbi:9606">children</span>
Pancreatic venous samplings in infants and children with primary hyperinsulinism.
###end article-title 84
###begin article-title 85
Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency.
###end article-title 85
###begin article-title 86
Cysteine residues are not essential for uncoupling protein function.
###end article-title 86
###begin article-title 87
Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation.
###end article-title 87
###begin article-title 88
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast mitochondrial metabolism: from in vitro to in situ quantitative study.
###end article-title 88
###begin article-title 89
###xml 135 146 <span type="species:ncbi:10141">guinea pigs</span>
The acute regulation of mitochondrial proton conductance in cells and mitochondria from the brown fat of cold-adapted and warm-adapted guinea pigs.
###end article-title 89
###begin article-title 90
A simplified system for generating recombinant adenoviruses.
###end article-title 90
###begin article-title 91
Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells.
###end article-title 91
###begin article-title 92
Retinoids activate proton transport by the uncoupling proteins UCP1 and UCP2.
###end article-title 92
###begin article-title 93
Increasing uncoupling protein-2 in pancreatic beta cells does not alter glucose-induced insulin secretion but decreases production of reactive oxygen species.
###end article-title 93
###begin article-title 94
Regulation of insulin secretion by uncoupling protein.
###end article-title 94
###begin article-title 95
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Uncoupling protein-2 modulates the lipid metabolic response to fasting in mice.
###end article-title 95
###begin article-title 96
###xml 109 113 <span type="species:ncbi:10090">mice</span>
Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice.
###end article-title 96
###begin article-title 97
Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells.
###end article-title 97
###begin article-title 98
Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity.
###end article-title 98
###begin article-title 99
Uncoupling protein-2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis-derived pyruvate utilization.
###end article-title 99
###begin article-title 100
###xml 45 62 45 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Toxoplasma gondii</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 45 62 <span type="species:ncbi:5811">Toxoplasma gondii</span>
Mice lacking uncoupling protein-2 survive to Toxoplasma gondii infection. A link with reactive oxygen species production and immunity.
###end article-title 100
###begin article-title 101
Role of uncoupling protein UCP2 in cell-mediated immunity: how macrophage-mediated insulitis is accelerated in a model of autoimmune diabetes.
###end article-title 101
###begin article-title 102
Mitochondrial Ca(2+), the secret behind the function of uncoupling proteins 2 and 3?
###end article-title 102
###begin article-title 103
The physiological regulation of uncoupling proteins.
###end article-title 103
###begin article-title 104
Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1.
###end article-title 104
###begin article-title 105
Familial leucine-sensitive hypoglycemia of infancy due to a dominant mutation of the beta-cell sulfonylurea receptor.
###end article-title 105
###begin article-title 106
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Endogenous islet uncoupling protein-2 expression and loss of glucose homeostasis in ob/ob mice.
###end article-title 106
###begin article-title 107
Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside.
###end article-title 107
###begin p 108
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 108
###begin p 109
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Academic support was obtained from the Centre National de la Recherche Scientifique and from the European Union (FP6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 109

